Reverse transcription
Unfractionated RNA (500 ng) are reverse transcribed in 21 ml for 60 min at 371C using 120 U of MMLV Reverse Transcriptase (Gibco/BRL), a mixture of 10 pmol each of fusion transcriptspecific decamers (Table 1) and conditions specified by the enzyme manufacturer.
PCR (a) Multiplex PCR:
1 A 5ml aliquot of cDNA from the terminated reverse transcription reaction was amplified by PCR on a Perkin-Elmer 9600 cycler using polypropylene, V bottom 96-well plates (Multiplate 96, MJ Research, Waltham, MA, USA) and AmpliTaq Gold polymerase (Perkin-Elmer). Primers and cycling conditions were essentially those described by Scurto et al 2 with modifications. Each 25 ml reaction contained a mixture of specific 5 0 and 3 0 primers, one of which is biotinylated (see Table 1 ), 80 mM dNTPs, 15 mM Tris pH 7.8, 3.5 mM MgCl 2 and 5% DMSO. After an initial denaturation step of 10 min at 951C, 14 cycles of 951C for 10, 64-501C for 1 min and 721C for 30 s were carried out decreasing the annealing temperature by 11C per cycle. This was followed by 35 cycles identical to the 14th cycle. The final extension was for 7 min. Reactions were then brought to 41C. RNA samples devoid of the translocations amplified by the assay as well as reactions containing no RNA were routinely included as negative and carry-over contamination controls, respectively. (b) Monoplex PCR: PCR reactions with identical composition to those in the multiplex reactions but containing only one pair of fusion transcript-specific primers were assembled and run using the same cycling parameters.
Analysis of PCR products
(a) Manufacture of the liquid bead microarray: The identity of the products amplified by multiplex PCR reactions was determined by solution hybridization with target-specific capture oligonucleotides covalently attached to XMAP beads (Luminex Corporation, Austin, TX, USA). XMAP beads are 5 mm polystyrene bead sets (total 100 sets) optically encoded with varying amounts of two spectrally distinguishable red fluorescent dyes (classification dyes) and functionalized with surface -COOH or -NH 2 by Luminex Corporation. Seven bead sets were used in the formulation of our translocation bead microarray, which resulted in a total assay read-through time of less than 30 s per sample (one patient per well of a 96-well microtiter plate). Carboxylated (Luminex) beads were coupled by the end-user to each oligonucleotide capture/probe using (1-ethyl-3-(dimethylaminopropyl)-carbodiimide hydrochloride EDC, Pierce, Rockford, IL, USA). EDC is a heterobifunctional crosslinking reagent that reacts with both the amino group present on the 5 0 end of each oligonucleotide capture/probe and the carboxyl groups present on the bead surface, leading to covalent coupling. Coupling efficiencies were established by reacting the conjugate beads with their cognate target oligonucleotides diluted to 20 nM. Beads that under these conditions fluoresced more than 1000 RFU passed our quality control for a given bead batch. After coupling bead concentration was adjusted to 5 Â 10 6 /ml and equal aliquots of each bead conjugate were combined onto a master bead microarray mix. Hybridizations were carried out in a 1 Â solution containing 3 M tetramethylammonium chloride (TMA), 0.1% sarcosyl, 50 mM Tris (pH 8.0) and 4 mM EDTA. At 3 M TMA changes in base staking result in a large decrease in the strength of GC pairing, which approaches that of AT pairs. 3 Therefore, the melting temperature of oligonucleotides becomes solely dependent on oligonucleotide length and largely, but not completely, independent of base content and context. 3 This permitted us to use dodecamers as capture oligonucleotides in a single tube hybridization reaction at a single hybridization temperature for all target PCR product/ probe combinations.
(b) Hybridization of RT-PCR products to the custom-made liquid bead microarray and data analysis: Hybridizations were initiated by transferring, with a multichannel pipette, 10 ml of terminated PCR reactions and 7 ml H 2 O into a 96-well multiplate containing 33 ml of bead microarrays suspended in 1.5 Â TMAC (1 Â ¼ 3 M TMA, 0.1% sarcosyl, 50 mM Tris, 4 mM EDTA). Hybridizations were initiated by codenaturation of the capture oligonucleotide/PCR product mix at 991C for 10 min and were carried out at 521C for 30 min. After hybridization samples were washed in 1X TMA, spun-down and resuspended in 1 Â TMA containing 10 mg/ml of streptavidin-phycoerythrin (Molecular Probes, OR, USA), incubated for 5 min at 521C, spun-down and resupended in 1 Â TMA. Samples were then automatically injected into the Luminex 100 analyzer using an XY platform manufactured by Luminex Corporation. The Luminex 100 analyzer is similar in concept to a flow cytometer and utilizes interlaced dual laser sources, one at 635 nm to excite the two classification fluorophores, and one at 532 nm to excite the reporter fluorophore. Numerical results were expressed as median light intensity units normalized to correct for background fluorescence and the varying hybridization efficiencies of the different target/capture probe combinations. The Luminex 100 instrument generates list mode data about the number of events recorded, their associated reporter fluorescence in 'relative fluorescence units', and several machine parameters important in quality control of the data. It displays the reporter fluorescence as a spreadsheet of cvs type. These data were transferred to a Microsoft Excel s file that had been programmed to subject the data to routines of background subtraction and normalization of signal intensity using the positive control signal as 100%. The data were then automatically displayed as a three-dimensional bar graph or as a conditionally color-coded spreadsheet, which allowed us to simultaneously graphically display the results for a large number of patients in a matter of seconds. The largest signal on samples negative for all targets by single target PCR was 8% of the positive control (relative light units), while the smallest signal of samples containing at least 10% leukemia cells was 48%. Owing to the large differences between positive and negative signals, we could operationally define a low minimum threshold signal of 10% of the positive control signal (unknown sample/ positive control Â 100) to distinguish between positive and negative samples.
(c) Gel electrophoresis of monoplex RT-PCR products: A volume of 5 ml of each terminated monoplex PCR reaction was loaded in a 2% agarose minigel prestained with ethidium bromide (Sigma). DNA size markers were from BioVentures Inc., Murfreesboro, TN, USA. Electrophoresis, at 100 V, was conducted for 1 h. Gels were photographed using polaroid film or imaged in a GelDoc s (BioRad, Hercules, CA, USA).
Time requirements
The time indicated above is the minimum time required to completely process 10 samples from cell isolation through result display. A greater number of samples does lead to an increase in processing time. In our hands 60 cases could be done in 7.5-8 h.
Sensitivity
The analytical sensitivity of the assay reproducibly was 1%. That is, the assay was consistently positive when RNA corresponding to one or more leukemia cells in 100 nonleukemia cells was present. This represents an ideal level of sensitivity for an assay intended to risk-stratify acute leukemia. Extremely high levels of sensitivity, although desirable for minimal residual disease follow-up, are less than optimal since some of these translocations may occur, albeit at a very low frequency, in cells that do not give origin to leukemia (multiple genetic hits hypothesis).
Specificity
Our assay detected all the translocations assayable by monoplex PCR in both mixing experiments (50 samples) and in patient samples. Furthermore, no known negative sample ever scored positive in this assay. Thus, for the group of translocations included in this study, the sensitivity, specificity, the positive predictive value and the negative predictive value are adequate for clinical use.
Reproducibility
The coefficient of variance was less than 3% for repeat reading of the same sample on Luminex 100. The coefficient of variation for multiple samples analyzed in succession, although larger at about 5%, was small enough to make readouts highly reproducible.
Cost Analysis
Only main consumables needed per test sample are included in the cost analysis below. For reagent sources see 'Reagents and solutions' below. FTE cost is not included since it varies significantly between Diagnostic Molecular Laboratories. Luminex 100 s (Austin, TX, USA). A 'dedicated' flow cytometer with dual interlaced lasers for excitation of classification dyes (bead number) and of a reported fluorophore. (3) Spectrophotometer (Pharmacia, Piscataway, NJ, USA).
Reagents and solutions

